T. Rowe Price Associates’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$75.6M Sell
2,274,249
-27,104
-1% -$901K 0.01% 629
2025
Q1
$67.4M Sell
2,301,353
-122,184
-5% -$3.58M 0.01% 633
2024
Q4
$79.6M Sell
2,423,537
-408,975
-14% -$13.4M 0.01% 623
2024
Q3
$126M Buy
2,832,512
+55,253
+2% +$2.45M 0.01% 522
2024
Q2
$120M Buy
2,777,259
+764,266
+38% +$33M 0.01% 509
2024
Q1
$58.9M Buy
2,012,993
+388,381
+24% +$11.4M 0.01% 685
2023
Q4
$36.2M Sell
1,624,612
-1,498
-0.1% -$33.4K ﹤0.01% 789
2023
Q3
$40.2M Buy
1,626,110
+332,718
+26% +$8.23M 0.01% 746
2023
Q2
$36.6M Buy
1,293,392
+29,695
+2% +$841K 0.01% 786
2023
Q1
$29M Sell
1,263,697
-216,497
-15% -$4.97M ﹤0.01% 826
2022
Q4
$41.6M Buy
1,480,194
+3,721
+0.3% +$104K 0.01% 709
2022
Q3
$41.8M Sell
1,476,473
-1,070,513
-42% -$30.3M 0.01% 700
2022
Q2
$56.5M Sell
2,546,986
-154,639
-6% -$3.43M 0.01% 836
2022
Q1
$78.6M Sell
2,701,625
-177,089
-6% -$5.16M 0.01% 808
2021
Q4
$94.6M Sell
2,878,714
-152,027
-5% -$5M 0.01% 785
2021
Q3
$140M Buy
3,030,741
+47,518
+2% +$2.19M 0.01% 664
2021
Q2
$164M Buy
2,983,223
+22,811
+0.8% +$1.26M 0.02% 624
2021
Q1
$153M Sell
2,960,412
-11,910
-0.4% -$615K 0.02% 634
2020
Q4
$129M Sell
2,972,322
-137,287
-4% -$5.95M 0.01% 641
2020
Q3
$109M Sell
3,109,609
-167,704
-5% -$5.87M 0.01% 631
2020
Q2
$175M Buy
3,277,313
+581,583
+22% +$31.1M 0.02% 500
2020
Q1
$95.6M Sell
2,695,730
-125,905
-4% -$4.47M 0.02% 586
2019
Q4
$135M Buy
2,821,635
+201,463
+8% +$9.62M 0.02% 575
2019
Q3
$84.9M Sell
2,620,172
-117,428
-4% -$3.8M 0.01% 673
2019
Q2
$137M Sell
2,737,600
-64,212
-2% -$3.2M 0.02% 562
2019
Q1
$189M Buy
2,801,812
+449,082
+19% +$30.3M 0.03% 485
2018
Q4
$108M Sell
2,352,730
-477,287
-17% -$22M 0.02% 586
2018
Q3
$218M Sell
2,830,017
-116,792
-4% -$9.01M 0.03% 464
2018
Q2
$248M Sell
2,946,809
-179,214
-6% -$15.1M 0.04% 416
2018
Q1
$256M Buy
3,126,023
+1,301,177
+71% +$106M 0.04% 403
2017
Q4
$104M Buy
1,824,846
+77,710
+4% +$4.44M 0.02% 624
2017
Q3
$117M Buy
1,747,136
+245,605
+16% +$16.4M 0.02% 586
2017
Q2
$77.3M Buy
1,501,531
+99,357
+7% +$5.11M 0.01% 684
2017
Q1
$81.9M Buy
1,402,174
+109,438
+8% +$6.39M 0.02% 650
2016
Q4
$53.9M Buy
1,292,736
+52,812
+4% +$2.2M 0.01% 784
2016
Q3
$65.5M Buy
1,239,924
+407,975
+49% +$21.5M 0.01% 707
2016
Q2
$34.9M Buy
831,949
+600,770
+260% +$25.2M 0.01% 905
2016
Q1
$9.39M Buy
231,179
+10,560
+5% +$429K ﹤0.01% 1287
2015
Q4
$14.3M Sell
220,619
-32,838
-13% -$2.13M ﹤0.01% 1192
2015
Q3
$17.9M Sell
253,457
-171,397
-40% -$12.1M ﹤0.01% 1126
2015
Q2
$47.2M Sell
424,854
-235,378
-36% -$26.2M 0.01% 859
2015
Q1
$62.3M Buy
660,232
+552,652
+514% +$52.1M 0.01% 760
2014
Q4
$12.1M Buy
+107,580
New +$12.1M ﹤0.01% 1270
2014
Q3
Sell
-1,019,913
Closed -$46.7M 2541
2014
Q2
$46.7M Buy
+1,019,913
New +$46.7M 0.01% 888
2013
Q4
Sell
-218,000
Closed -$6.1M 2480
2013
Q3
$6.1M Buy
+218,000
New +$6.1M ﹤0.01% 1387